IMR Press / RCM / Volume 25 / Issue 3 / DOI: 10.31083/j.rcm2503097
Open Access Review
Embolic Events in Infective Endocarditis: A Comprehensive Review
Show Less
1 Instituto de Ciencias del Corazón (ICICOR), Cardiology Department, Hospital Clínico Universitario, 47003 Valladolid, Spain
2 Ciber de Enfermedades Cardiovasculares (CIBER CV), Instituto de investigación Carlos III, 28029 Madrid, Spain
3 Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdSSC), 28040 Madrid, Spain
4 Servicio de Neurología del Hospital Clínico Universitario de Valladolid, 47003 Valladolid, Spain
*Correspondence: gonzavilla10@hotmail.com (Gonzalo Cabezon)
These authors contributed equally.
Rev. Cardiovasc. Med. 2024, 25(3), 97; https://doi.org/10.31083/j.rcm2503097
Submitted: 20 September 2023 | Revised: 27 December 2023 | Accepted: 11 January 2024 | Published: 7 March 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Infective endocarditis (IE) is a life-threating entity with three main complications: heart failure (HF), uncontrolled infection (UI) and embolic events (EEs). HF and UI are the main indications of cardiac surgery and have been studied thoroughly. On the other hand, much more uncertainty surrounds EEs, which have an abrupt and somewhat unpredictable behaviour. EEs in the setting of IE have unique characteristics that must be explored, such as the potential of hemorrhagic transformation of stroke. Accurately predicting which patients will suffer EEs seems to be pivotal to achieve an optimal management of the disease, but this complex process is still not completely understood. The indication of cardiac surgery in order to prevent EEs in the absence of HF or UI is in question as scientific evidence is controversial and mainly of a retrospective nature. This revision addresses these topics and try to summarize the evidence and recommendations about them.

Keywords
infective endocarditis
embolic events
stroke
mycotic aneurysm
Funding
PI22/00459/Instituto de Salud Carlos III
GRS2657/A/22/Gerencia Regional de Salud de Castilla y León
Figures
Fig. 1.
Share
Back to top